Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7802511 | 0.94 | AKR1C3 (0.30) | AKR1C3 | |
| SCHEMBL7938680 | 0.94 | MT-CO2 (0.32) | — | |
| SCHEMBL7787570 | 0.89 | AKR1C3 (0.33) | PTGS2AKR1C3 | |
| SCHEMBL7804341 | 0.89 | CA2 (0.37) | — | |
| SCHEMBL7800486 | 0.89 | CA2 (0.37) | AKR1C3 | |
| SCHEMBL7802481 | 0.87 | MEN1 (0.35) | PTGS2AKR1C3 | |
| SCHEMBL7932216 | 0.86 | AKR1C3 (0.31) | AKR1C3 | |
| SCHEMBL7941503 | 0.86 | MT-CO2 (0.36) | — | |
| SCHEMBL7784773 | 0.81 | MAPT (0.36) | PTGS2AKR1C3 | |
| SCHEMBL7784784 | 0.79 | MT-CO2 (0.39) | AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140062-A2 | TREATMENT OF ASTHMA WITH MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1140067-A1 | ANTIVIRAL METHOD USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000040235-A2 | TREATMENT OF ASTHMA WITH MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-13 | — | — | WO | disclosed |
| WO-2000040237-A1 | ANTIVIRAL METHOD USING MEK INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2000-07-13 | — | — | WO | disclosed |